Octagon Capital Advisors’s ARS Pharmaceuticals SPRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.6M Buy
1,350,000
+725,000
+116% +$12.7M 5.17% 5
2025
Q1
$7.86M Buy
+625,000
New +$7.86M 1.52% 24